LUBOX | LUBYX | LUBOX / LUBYX | |
Total Expense Ratio | 0.24 | 0.28 | 86% |
Annual Report Gross Expense Ratio | 0.24 | 0.28 | 86% |
Fund Existence | 8 years | 9 years | - |
Gain YTD | 2.855 | 2.821 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.6B | 13.6B | 100% |
Annual Yield % from dividends | 4.95 | 4.90 | 101% |
Returns for 1 year | 5.30 | 5.24 | 101% |
Returns for 3 years | 17.13 | 16.93 | 101% |
Returns for 5 years | 16.35 | 16.05 | 102% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IHOIX | 20.80 | N/A | N/A |
Hartford International Opportunities I | |||
FPHAX | 23.79 | N/A | N/A |
Fidelity Select Pharmaceuticals Port | |||
OLGAX | 84.38 | N/A | N/A |
JPMorgan Large Cap Growth A | |||
SBRVX | 14.69 | N/A | N/A |
Segall Bryant & Hamill Sm Cp Val Ret | |||
MCYAX | 11.63 | -0.13 | -1.11% |
NYLI Candriam Emerging Markets Eq Cl A |